VRDN EPS Estimates - Viridian Therapeutics, Inc. logo

VRDN EPS Estimates

Viridian Therapeutics, Inc.

$30.12
+$0.06(+0.20%)
59
Overall
60
Value
83
Tech
34
Quality
How is this score calculated?
Market Cap
$3.42B
Volume
1.49M
52W Range
$13.18 - $34.29
Target Price
$42.06

VRDN EPS estimates: the consensus estimate for Viridian Therapeutics, Inc.'s current fiscal year is -$3.64 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.

VRDN EPS Estimates

EPS estimate, current quarter
$-0.81
EPS estimate, next quarter
$-0.61
EPS estimate, current year
$-3.64
EPS estimate, next year
$-2.13
EPS growth, 3-year
+6.41%
VRDN reported EPS by year
Fiscal yearEPS
2025$-3.32
2024$-3.07
2023$-5.31
2022$-4.05
2021$-6.66
ABCD
1SymbolPriceChangeVol
2VRDN$30.12+0.2%1.49M
3
4
5
6

Get Viridian Therapeutics, Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.